Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Stephen A. Brunton & Carol H. Wysham. (2020) GLP-1 receptor agonists in the treatment of type 2 diabetes: role and clinical experience to date. Postgraduate Medicine 132:sup2, pages 3-14.
Read now
Read now
Clementine Nordon, Constance Battin, Helene Verdoux, Josef Maria Haro, Mark Belger, Lucien Abenhaim & Tjeerd Pieter van Staa. (2017) The use of random-effects models to identify health care center-related characteristics modifying the effect of antipsychotic drugs. Clinical Epidemiology 9, pages 689-698.
Read now
Read now
Articles from other publishers (16)
Yat Hang To, Peter Gibbs, Jeanne Tie, Maarten IJzerman & Koen Degeling. (2023) Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review. Cost Effectiveness and Resource Allocation 21:1.
Crossref
Crossref
Christian Vogelberg, Ludger Klimek, Bernd Brüggenjürgen & Marek Jutel. (2022) Real‐world evidence for the long‐term effect of allergen immunotherapy: Current status on database‐derived European studies. Allergy 77:12, pages 3584-3592.
Crossref
Crossref
Sandra Jent, Bez Natalie, Loan Catalano & Gerhard Rogler. (2022) The efficacy of a diet low in fermentable oligo-, di-, monosaccharides and polyols in irritable bowel syndrome compared to its "real-world" effectiveness: a systematic review protocol (Preprint). JMIR Research Protocols.
Crossref
Crossref
Rashmi Shetty, Fathima Thashreefa Basheer, Pooja Gopal Poojari, Girish Thunga, Viji Pulikkel Chandran & Leelavathi D. Acharya. (2022) Adverse drug reactions of GLP-1 agonists: A systematic review of case reports. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 16:3, pages 102427.
Crossref
Crossref
Milou A. Hogervorst, Johan Pontén, Rick A. Vreman, Aukje K. Mantel-Teeuwisse & Wim G. Goettsch. (2022) Real World Data in Health Technology Assessment of Complex Health Technologies. Frontiers in Pharmacology 13.
Crossref
Crossref
Anthime Flaus, Vincent Habouzit, Nicolas de Leiris, Jean-Philippe Vuillez, Marie-Thérèse Leccia, Mathilde Simonson, Jean-Luc Perrot, Florent Cachin & Nathalie Prevot. (2022) Outcome Prediction at Patient Level Derived from Pre-Treatment 18F-FDG PET Due to Machine Learning in Metastatic Melanoma Treated with Anti-PD1 Treatment. Diagnostics 12:2, pages 388.
Crossref
Crossref
Lola A. Coke, Prakash C. Deedwania, Debbie Hinnen, Melissa Magwire & Nancy H. Miller. (2022) GLP-1 receptor agonists and cardiovascular outcomes in patients with type 2 diabetes: Clinical evidence and best practice. Journal of the American Association of Nurse Practitioners 34:2, pages 418-440.
Crossref
Crossref
Donald J. AbrahamPat McCollam, Julie Birt & Theresa Hunter. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
13
.
Rick A. Vreman, Svetlana V. Belitser, Ana T.M. Mota, Anke M. Hövels, Wim G. Goettsch, Kit C.B. Roes, Hubert G.M. Leufkens & Aukje K. Mantel‐Teeuwisse. (2020) Efficacy gap between phase II and subsequent phase III studies in oncology. British Journal of Clinical Pharmacology 86:7, pages 1306-1313.
Crossref
Crossref
Arnoud J. Templeton, Christopher M. Booth & Ian F. Tannock. (2020) Informing Patients About Expected Outcomes: The Efficacy-Effectiveness Gap. Journal of Clinical Oncology 38:15, pages 1651-1654.
Crossref
Crossref
Tine Geldof, Nancy Van Damme, Isabelle Huys & Walter Van Dyck. (2020) Patient-Level Effectiveness Prediction Modeling for Glioblastoma Using Classification Trees. Frontiers in Pharmacology 10.
Crossref
Crossref
Reynaldo Martina, David Jenkins, Sylwia Bujkiewicz, Pascale Dequen & Keith Abrams. (2018) The inclusion of real world evidence in clinical development planning. Trials 19:1.
Crossref
Crossref
Fernanda S. Tonin, Laiza M. Steimbach, Leticia P. Leonart, Vinicius L. Ferreira, Helena H. Borba, Thais Piazza, Ariane G. Araújo, Fernando Fernandez-Llimos, Roberto Pontarolo & Astrid Wiens. (2018) Discontinuation of non-anti-TNF drugs for rheumatoid arthritis in interventional versus observational studies: a systematic review and meta-analysis. European Journal of Clinical Pharmacology 74:11, pages 1513-1521.
Crossref
Crossref
Kelsey L. Hawkins & Ives Hot. (2018) Retrospective Cohort Study: Ledipasvir-Sofosbuvir With/Without Ribavirin for Chronic Hepatitis C Post–Liver Transplant in a Real-World Population. Journal of Pharmacy Technology 34:5, pages 199-203.
Crossref
Crossref
Matteo Monami, Francesco Liistro, Alessia Scatena, Besmir Nreu & Edoardo Mannucci. (2018) Short and medium‐term efficacy of sodium glucose co‐transporter‐2 (SGLT‐2) inhibitors: A meta‐analysis of randomized clinical trials. Diabetes, Obesity and Metabolism 20:5, pages 1213-1222.
Crossref
Crossref
Ashly E. Jordan, David C. Perlman, Daniel J. Smith, Jennifer R. Reed & Holly Hagan. (2018) Use of the PRECIS-II instrument to categorize reports along the efficacy-effectiveness spectrum in an hepatitis C virus care continuum systematic review and meta-analysis. Journal of Clinical Epidemiology 93, pages 66-75.
Crossref
Crossref